Delivery Order SPE2DB25D3201-SPE2DB25FNWLC
Award Date 9/12/25
Potential Completion Date 10/3/25
Potential Value $14K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Enhertu 100 mg vials, valued at $8,888.50 with a firm fixed price arrangement. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The award was made through open competition with no set-aside designation,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $17,777.00 to supply 100 mg vials of Enhertu, a prescription oncology medication, with an ultimate completion date of September 15, 2025. This non-set-aside delivery order employs firm fixed pricing and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, one of the nation's largest pharmaceutical distributors, was competitively...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Enhertu 100 mg vials, valued at $17,777.00, with a completion date of September 23, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Enhertu 100 mg vials valued at $10,666.20 with a firm fixed price structure. This delivery order represents a child contract under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and running through December 2026. The award involved no set-aside designation, indicating competitive...
- The Defense Logistics Agency awarded a $17,777 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 100 mg vials of Enhertu, a oncology therapeutic agent used in cancer treatment. The contract was competitively awarded without set-aside restrictions and carries an ultimate completion date of September 24, 2025. AmerisourceBergen will perform this delivery order from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a...
- The Defense Logistics Agency awarded a $10,666.20 delivery order to AmerisourceBergen Drug Corp for 100 mg vials of Enhertu, a prescription oncology medication used in cancer treatment. This firm fixed-price delivery order, issued on August 13, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The award was made through open competition with no set-aside...
- The Defense Logistics Agency awarded a $7,110.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Enhertu 100 mg vials, with an ultimate completion date of September 24, 2025. This non-set-aside award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery location is AmerisourceBergen's...
- The Defense Logistics Agency awarded a $35,554 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Enhertu 100 mg vials, with an ultimate completion date of September 25, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive $999,999,999 pharmaceutical supply vehicle running through December 2026....
- The Defense Logistics Agency awarded a delivery order valued at $17,777.00 to AmerisourceBergen Drug Corp for 100 mg vials of Enhertu, a oncology medication used in cancer treatment. This firm fixed price delivery order, awarded on August 19, 2025, with a completion date of September 10, 2025, represents a competitive award with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order operates...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 100 mg vials of Enhertu, a specialty pharmaceutical product, with a ceiling value of $7,110.80. This firm fixed-price delivery order was competitively awarded without set-aside provisions and is scheduled for completion by September 29, 2025. The award leverages AmerisourceBergen's established Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion global...